Camardo Daniel A.
- SEC CIK
- 0001820365
No open-market purchases or sales filed in the past year.
Current role at each company
- CUE Cue Biopharma, Inc.Directoras of Jul 10, 2026
- ATHX Athersys, IncCEOas of Oct 6, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Camardo Daniel A. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ATHX Athersys, Inc
CEO2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 22, 2022 (view filing) | Nov 22 | Same day | Camardo Daniel A.CEO | PPurchase | +100.0K | $0.55 | +$55.0K | +37.2%368.8K after | |
| Mar 17, 2022 (view filing) | Mar 17 | Same day | Camardo Daniel A.CEO | PPurchase | +132.8K | $0.77 | +$102.3K | New position132.8K after |